Naturally Splendid Enterprises Ltd. (TSXV:NSP) (“Naturally Splendid” or “NSE” or “The Company”) (OTCQB:NSPDF) (Frankfurt:50N) is pleased to announce it has officially launched NATERA FX™, an industry first hemp-based, practitioner grade of therapeutic healthcare products at the British Columbia Naturopathic Association’s (BCNA’s) Advancing Naturopathic Medicine 2018 Exhibition in Vancouver, British Columbia on October 12, 2018.

Naturally Splendid is pleased to have received an initial commitment of over $500,000 CDN from its Master Distributor who has access to over 2,000 naturopaths and healthcare professionals across Canada. The NATERA FX™ products are designed to assist healthcare professionals optimize the nutritional “tool kits” within their existing lifestyle programs.

NATERA FX™ products will be marketed directly to healthcare professionals including but not limited to; naturopaths; chiropractors; medical doctors; and pharmacies through a country-wide network of distributors and an e-commerce website at:

NATERA FX™ currently has 5 products that have received Natural Product Numbers (NPN’s) from Health Canada as follows:

    Relief: Anti Inflammatory Capsules (NPN # 80082780)

    Phyto Mood: Capsules (NPN # 80084609)

    Lean FX: Body Composition Formula – Chocolate Banana (NPN # 80087708)

    Lean FX: Body Composition – Vanilla Carmel (NPN # 80087708)

    MVP: Multi Vitamin Phyto Nutrient (NPN # 80085246)

Additionally, NSE has submitted an NPN application and is awaiting acceptance for the following:

    MATRIX: Bone & Joint Health Capsules (expected December 2018)

NATERA FX™ has 5 other professionally formulated products developed for this line that do not require NPN numbers as follows:

    Phyto Shake: Hemp Protein & Phytonutrient Blend – Chocolate Banana

    Phyto Shake: Hemp Protein & Phytonutrient Blend – Vanilla Caramel

    KETO Bars: Mango, Vanilla Chai, Super Greens, Hemp Heart Beet, Chocolate Maple Hazelnut, &     Blueberry Lemon

    DiaFibre: – Higher levels of soluble fibre for rapid gut motility – Tropical Mango

    ConstiFibre: – Higher levels of insoluble fibre for passive gut motility – Pineapple Coconut

Bryan Carson, Naturally Splendid Executive Vice President of Marketing & Innovation stated, “This is a very exciting product launch as there are no comparable hemp-based products currently being marketed directly to healthcare practitioners. We have been working closely with doctors and formulators for almost 18 months to create a superior hemp product line designed for the practitioner market and we will continue to develop additional products and add SKUs strategically. NSE also plans to add cannabidiol (CBD) and other cannabinoids into future formulations as regulations allow.”

Additionally, Naturally Splendid has engaged the services of Mr. Michael Li and WELLGENEX Sciences Inc. to guide the company and provide services to apply for Natural Product Numbers (NPN’s) from Health Canada.

Michael Z.C. Li, MD, MSc, MBA has over 25 years of experience in the medical, nutrition, and natural health products sectors in Asia Pacific and North America with expertise in R&D, clinical trials, technology assessment, new product development, commercialization, business and market development as well as strategic planning. He has worked as a general physician and held various positions and project management roles in a number of private, public and multinational companies including the Kraft Heinz Company, Chai-Na-Ta Corp., National Research Council Canada, and Zuellig Group.

Wellgenex Sciences is a full-service professional company devoted to helping clients in life sciences, nutrition and natural health to bring innovative technologies and products to target marketplaces in Canada, the U.S. and Asia Pacific.

Scientific & Regulatory Affairs

  • Product registration & regulatory approvals
  • Intellectual property and technology management
  • Product specification set-up, claim and labeling
  • Evidence requirement and assessment
  • Clinical trials

Product Development & Commercialization

  • Technical appraisal and scientific support
  • Product review, market assessment and regulatory feasibility
  • Technical appraisal and scientific support
  • Formulation and optimization
  • Clinical trials

Market Development & Investment

  • Market research
  • Feasibility & entry strategy
  • Strategic alliances
  • Investment evaluation and due diligence
  • Strategic alliances and business planning

About Naturally Splendid Enterprises Ltd.

Naturally Splendid is a biotechnology and consumer products company that is developing, producing, commercializing, and licensing an entirely new generation of plant-derived, bioactive ingredients, nutrient dense foods, and related products. Naturally Splendid is building an expanding portfolio of patents (issued and pending) and proprietary intellectual property focused on the commercial uses of industrial hemp and marijuana cannabinoid compounds in a broad spectrum of applications.

For more information e-mail or call Investor Relations at 604-673-9573

On Behalf of the Board of Directors

Mr. Douglas Mason

CEO, Director

Contact Information

Naturally Splendid Enterprises Ltd.

(NSP – TSX Venture; NSPDF – OTCQB; 50N Frankfurt)

#108-19100 Airport Way

Pitt Meadows, BC, V3Y 0E2

Office: (604) 465-0548

Fax:     (604) 465-1128



Forward-Looking Statements

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid’s control including, Naturally Splendid’s ability to compete with large food and beverage companies; sales of any potential products developed will be profitable; sales of shelled hemp seed will continue at existing rates or increase; the ability to complete the sales of all bulk hemp seed purchase orders; and the risk that any of the potential applications may not receive all required regulatory or legal approval. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information.


Click here to connect with Naturally Splendid Enterprises Ltd. (TSXV:NSP) (OTCQB:NSPDF) (Frankfurt:50N) for an Investor Presentation


Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less